EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention

Zihao Xia, Chen Lin, Yi Wu, Hongshuai Liu iD, Linrong Wu, Zhisen Shen iD

International Journal of General Medicine · 2026-08 · Volume 19 · 1-20

DOI: 10.2147/ijgm.s623974 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of General Medicine, 2026-08. Verfasst von Zihao Xia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, 315040, People's Republic o…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related hearing loss (ARHL) is a prevalent neurosensory impairment. Traditional audiometry is post-symptomatic, fundamentally failing to capture the molecular deterioration that precedes clinical hearing decline by years. To address this gap, the clinical paradigm is urgently shifting toward precision medicine. This review summarizes emerging molecular biomarkers enabling the early detection, patient stratification, and targeted prevention of ARHL. We systematically evaluate the clinical measurability and diagnostic value of biomarkers across core pathological axes: cellular senescence, inner ear apoptosis, chronic inflammaging, oxidative stress, and genetic variants. Crucially, we highlight how these molecular signatures show preclinical promise as future actionable targets for personalized interventions, including novel anti-inflammatory, antioxidant, and gene therapies. Finally, we explore the future potential of integrating these preliminary indicators into comprehensive biomarker panels. We conceptualize a theoretical precision diagnostics framework that synthesizes genomic, inflammatory, and oxidative profiles. While acknowledging that current evidence is predominantly based on mechanistic and preclinical studies requiring extensive human clinical validation, this proposed framework aims to guide future translational research. Ultimately, this conceptual approach lays the groundwork for discovering early interventions that could delay disease progression and improve long-term auditory prognosis.

Schlagwörter

Stichwörter der Autor:innen

age-related hearing lossinflammagingmolecular biomarkersprecision diagnosticstargeted prevention

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, 315040, People's Republic of China.
  • Health Science Center, Ningbo University, Ningbo, People's Republic of China.

ORCID-Profile: Hongshuai Liu, Zhisen Shen

Zitieren

APA

Xia, Z., Lin, C., Wu, Y., Liu, H., Wu, L., & Shen, Z. (2026). Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention. International Journal of General Medicine, Volume 19, 1-20. https://doi.org/10.2147/ijgm.s623974

Vancouver

Xia Z, Lin C, Wu Y, Liu H, Wu L, Shen Z. Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention. International Journal of General Medicine. 2026;Volume 19:1-20. doi:10.2147/ijgm.s623974

BibTeX
@article{Xia2026,
  author = {Xia, Zihao and Lin, Chen and Wu, Yi and Liu, Hongshuai and Wu, Linrong and Shen, Zhisen},
  title = {Precision Diagnostics in Age-Related Hearing Loss: Emerging Molecular Biomarkers for Early Detection and Targeted Prevention},
  journal = {International Journal of General Medicine},
  year = {2026},
  volume = {Volume 19},
  pages = {1--20},
  doi = {10.2147/ijgm.s623974}
}
Kostenlos starten →